Evidence and clinical judgment: Treatment of cerebral vein thrombosis

Walter Ageno; Francesco Dentali; Alessandro Squizzato; Trevor Baglin; James Douketis; Martin Lansberg; Maurizio Paciaroni; Gualtiero Palareti

doi:10.1160/TH09-12-0827

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2010; 103(06): 1109-1115
DOI: 10.1160/TH09-12-0827

SISET Guideline Series

Schattauer GmbH

Evidence and clinical judgment^[*]: Treatment of cerebral vein thrombosis

Authors

Walter Ageno

¹Department of Clinical Medicine, University of Insubria, Varese, Italy
Francesco Dentali

¹Department of Clinical Medicine, University of Insubria, Varese, Italy
Alessandro Squizzato

¹Department of Clinical Medicine, University of Insubria, Varese, Italy
Trevor Baglin

²Department of Hematology, Cambridge University, Cambridge, UK
James Douketis

³Department of Medicine, McMaster University, Hamilton, Canada
Martin Lansberg

⁴Stanford Stroke Center, Stanford University Medical Center, Palo Alto, USA
Maurizio Paciaroni

⁵Department of Vascular Medicine and Stroke Unit, University of Perugia, Perugia, Italy
Gualtiero Palareti

⁶Department of Angiology, University of Bologna, Bologna, Italy

Abstract

Full Text

References

References
1 Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005; 352: 1791-1798.
2 Bousser MG, Ferro JM. Cerebral venous thrombosis; an update. Lancet Neurol 2007; 06: 162-170.
3 Van den Bergh WM, van der Schaaf I, van Gijn J. The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis. Neurology 2005; 65: 192-196.
4 Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35: 664-670.
5 Albers GW, Amarenco P, Easton JD. et al. American College of Chest Physicians. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8^th Edition). Chest 2008; 133 (Suppl. 06) 630S-669S.
6 Sacco RL, Adams R, Albers G. et al American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology.. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke. Circulation 2006; 113: e409-449.
7 Scottish Intercollegiate Guideline Network.. Management of patients with stroke or TIA: assessment, investigation, immediate management and secondary prevention 2008. http://www.sign.ac.uk/guidelines/fulltext/108/index.html accessed on August 24^th, 2009.
8 SPREAD.. Stroke Prevention and Educational Awareness Diffusion. 5^th edition 2007 http://www.spread.it accessed on August 24^th, 2009.
9 Einhaupl KM, Villringer A, Meister W. et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338: 597-600.
10 de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30: 484-488.
11 Stam J, De Bruijn SF, DeVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev 2002; 04: CD002005.
12 Ciccone A, Canhão P, Falcão F. et al. Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Syst Rev 2004; 01: CD003693.
13 Canhão P, Falcão F, Ferro JM. Thrombolytics for cerebral sinus thrombosis: a systematic review. Cerebrovasc Dis 2003; 15: 159-166.
14 Dentali F, Gianni M, Crowther MA. et al. Natural history of cerebral vein thrombosis: a systematic review. Blood 2006; 108: 1129-1134.

Evidence and clinical judgment[*]: Treatment of cerebral vein thrombosis

Authors

Evidence and clinical judgment^[*]: Treatment of cerebral vein thrombosis